Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Pharmacopsychiatry
|
July 6, 2026
Editorial
Georgios Schoretsanitis, Stefan Unterecker, Xenia M Hart
Frontiers in Psychiatry
|
April 25, 2022
Molecular Imaging of Dopamine Partial Agonists in Humans: Implications for Clinical Practice
Xenia M Hart, Christian N Schmitz, Gerhard Gründer
Therapeutic Drug Monitoring
|
November 29, 2023
Update Lessons from Positron Emission Tomography Imaging Part I: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antipsychotics
Xenia M Hart, Moritz Spangemacher, Hiroyuki Uchida, et al.
Pharmacopsychiatry
|
February 22, 2024
Unraveling the Influence of Age, IQ, Education, and Negative Symptoms on Neurocognitive Performance in Schizophrenia: A Conditional Inference Tree Analysis
Xenia M Hart, Yasue Mitsukura, Robert R Bies, et al.
Pharmacopsychiatry
|
March 21, 2023
Low Escitalopram Concentrations in Patients with Depression predict Treatment Failure: A Naturalistic Retrospective Study
Xenia M Hart, Friederike Amann, Jonas Brand, et al.
Therapeutic Drug Monitoring
|
January 30, 2024
Update Lessons from PET Imaging Part II: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antidepressants
Xenia M Hart, Moritz Spangemacher, Julie Defert, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
October 9, 2025
Serum concentrations of selective serotonin reuptake inhibitors and atypical antipsychotics in children and adolescents: data from routine clinical care
Sophie Wiegand, Xenia M Hart, Karin M Egberts, et al.
Frontiers in Psychiatry
|
December 13, 2021
Therapeutic Reference Ranges for Psychotropic Drugs: A Protocol for Systematic Reviews
Xenia M Hart, Luzie Eichentopf, Xenija Lense, et al.
Translational Psychiatry
|
October 1, 2025
The sense and nonsense of antipsychotic combinations: A model for dopamine D<sub>2/3</sub> receptor occupancy
Moritz Spangemacher, Christian N Schmitz, Paul Cumming, et al.
Therapeutic Drug Monitoring
|
March 21, 2023
Behind the Curtain: Therapeutic Drug Monitoring of Psychotropic Drugs from a Laboratory Analytical Perspective
Maike Scherf-Clavel, Pierre Baumann, Xenia M Hart, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Pharmacopsychiatry
|
July 6, 2026
Editorial
Georgios Schoretsanitis, Stefan Unterecker, Xenia M Hart
Frontiers in Psychiatry
|
April 25, 2022
Molecular Imaging of Dopamine Partial Agonists in Humans: Implications for Clinical Practice
Xenia M Hart, Christian N Schmitz, Gerhard Gründer
Therapeutic Drug Monitoring
|
November 29, 2023
Update Lessons from Positron Emission Tomography Imaging Part I: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antipsychotics
Xenia M Hart, Moritz Spangemacher, Hiroyuki Uchida, et al.
Pharmacopsychiatry
|
February 22, 2024
Unraveling the Influence of Age, IQ, Education, and Negative Symptoms on Neurocognitive Performance in Schizophrenia: A Conditional Inference Tree Analysis
Xenia M Hart, Yasue Mitsukura, Robert R Bies, et al.
Pharmacopsychiatry
|
March 21, 2023
Low Escitalopram Concentrations in Patients with Depression predict Treatment Failure: A Naturalistic Retrospective Study
Xenia M Hart, Friederike Amann, Jonas Brand, et al.
Therapeutic Drug Monitoring
|
January 30, 2024
Update Lessons from PET Imaging Part II: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antidepressants
Xenia M Hart, Moritz Spangemacher, Julie Defert, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
October 9, 2025
Serum concentrations of selective serotonin reuptake inhibitors and atypical antipsychotics in children and adolescents: data from routine clinical care
Sophie Wiegand, Xenia M Hart, Karin M Egberts, et al.
Frontiers in Psychiatry
|
December 13, 2021
Therapeutic Reference Ranges for Psychotropic Drugs: A Protocol for Systematic Reviews
Xenia M Hart, Luzie Eichentopf, Xenija Lense, et al.
Translational Psychiatry
|
October 1, 2025
The sense and nonsense of antipsychotic combinations: A model for dopamine D<sub>2/3</sub> receptor occupancy
Moritz Spangemacher, Christian N Schmitz, Paul Cumming, et al.
Therapeutic Drug Monitoring
|
March 21, 2023
Behind the Curtain: Therapeutic Drug Monitoring of Psychotropic Drugs from a Laboratory Analytical Perspective
Maike Scherf-Clavel, Pierre Baumann, Xenia M Hart, et al.
Page
of 2